Dietary Effects on Cardiovascular Disease Risk Factors: Beyond Saturated Fatty Acids and Cholesterol

Journal of the American College of Nutrition

Volumn 20, Issue , 2001, Pages 421S-427S

  Nicolosi, Robert J ^a   Wilson, Thomas A ^a   Lawton, Carl ^a   Handelman, Garry J ^a  

^a University of Massachusetts   (United States)

Author keywords

Corn fiber oil; Fiber; Homocysteinemia; Hypercholesterolemia; Lecithin; Phytosterols; Rice bran oil; Saturated fat; Soy protein

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE; PHYTOSTEROL; POLYPHENOL; PYRIDOXINE; SATURATED FATTY ACID; SOYBEAN PROTEIN;

CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; HUMAN; HYPERCHOLESTEROLEMIA; NUTRITION; RISK FACTOR; TREATMENT PLANNING;

CARDIOVASCULAR DISEASES; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, FAT-RESTRICTED; DIETARY FATS; DIETARY FATS, UNSATURATED; DIETARY SUPPLEMENTS; HEALTH FOOD; HUMANS; HYPERCHOLESTEROLEMIA; RISK FACTORS; TREATMENT OUTCOME;

EID: 0034796161     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2001.10719179     Document Type: Article

References (70)

1. Krauss RM, Eckel RH, Howard B, et al: AHA dietary guidelines. Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102: 2284-2299, 2000.
2. NCEP Expert Panel: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269: 3015-3023, 1993.
3. Mattson FH, Grundy, SM: Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 26: 194-202, 1985.
4. McDonald BE, Gerrard JM, Bruce VM, Corner EJ: Comparison of the effect of canola oil and sunflower oil on plasma lipids and lipoproteins and on in vivo thromboxane A2 and prostacyclin production in healthy young men. Am J Clin Nutr 50: 1382-1388, 1989.
5. Mensink RP, Katan MB: Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N Engl J Med 321: 436-441, 1989.
6. Hegsted DM, Ausman LM, Johnson JA, Dallal GE: Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr 57: 875-883, 1993.
7. Barr SL, Ramakrishnan R, Johnson C, Holleran S, Dell RB, Ginsberg HN: Reducing total dietary fat without reducing saturated fatty acids does not significantly lower total plasma cholesterol concentrations in normal males. Am J Clin Nutr 55: 675-681, 1992.
8. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, Contois JH, Li Z, Goldin BR, Rasmussen H, McNamara JR, Ordovas JM: Effects of National Cholesterol Education Program Step 2 diets relatively high or relatively low in fish-derived fatty acids on plasma lipoproteins in middle-aged and elderly subjects. Am J Clin Nutr 63: 234-241, 1996.
9. Anderson JW, Johnstone BM, Cook-Newell ML: Meta-Analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333: 276-282, 1995.
10. Carroll KK: Review of clinical studies on cholesterol-lowering response to soy protein. J Am Dietetic Assoc 91: 820-827, 1991.
11. Meinertz H, Nilausen K, Faergeman O: Soy protein and casein in cholesterol-enriched diets: effects on plasma lipoproteins in normolipidemic subjects. Am J Clin Nutr 50: 786-793, 1989.
12. Potter SM, Bakhit RM, Essex-Sorlie D, Weingartner KE, Chapman KM, Nelson RA, Prabhudesai M, Savage WD, Nelson AI, Winter LW, Erdman JW: Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am J Clin Nutr 58: 501-506, 1993.
13. Gooderham MJ, Aldercreutz H, Ojala ST, Wahala K, Holub BJ: A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 126: 2000-2006, 1996.
14. Potter SM: Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125(Suppl): 606-611, 1995.
15. Anthony MS, Clarkson TB, Bullock BC, Wagner JD: Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis on male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 17: 2524-2531, 1997.
16. Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL: A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 159: 2020-2076, 1999.
17. Anderson JW, Jones AE, Riddell-Mason S: Ten different dietary fibers have significantly different effects on serum and liver lipids of cholesterol-fed rats. J Nutr 124: 78-83, 1994.
18. Anderson JW, Spencer DB, Hamilton CC, Smith SF, Tietyen J, Bryant CA, Oeltgen D: Oat bran cereal lowers serum total and LDL cholesterol in hypercholesterolemic men. Am J Clin Nutr 52: 495-499, 1990.
19. Nicolosi RJ, Bell SJ, Bistrian BR, Greenberg I, Forse AF, Blackburn GL: Plasma lipid changes after supplementation with -glucan fiber. Am J Clin Nutr 70: 208-212, 1999.
20. Clark SB, Clark VE, Small DM: Effects of lecithin ingestion on plasma and lymph lipoproteins of normo-and hyperlipemic rats. Am J Physiol 241: 422-430, 1981.
21. Hunt CE, Duncan LA: Hyperlipoproteinaemia and atherosclerosis in rabbits fed low-level cholesterol and lecithin. Br J Exp Pathol 66: 35-46, 1985.
22. Wilson TA, Meservey CM, Nicolosi RJ: Soy lecithin reduces plasma lipoprotein cholesterol and early atherosclerosis in hypercholesterolemic monkeys and hamsters: beyond linoleate. Atherosclerosis 140: 147-153, 1998.
23. Wong EK, Nicolosi RJ, Low PA, Herd JA, Hayes K: Lecithin influence on hyperlipemia in rhesus monkeys. Lipids 15: 428-433, 1980.
24. Blaton V, Soetewey F, Vandamme D, Declerq B, Peeters H: Effect of polyunsaturated phosphatidylcholine on human types II and IV hyperlipoproteinemias. Artery 2: 309-325, 1976.
25. Childs MT, Bowlin JA, Oglivie JT, Hazzard WR, Albers JJ: The contrasting effects of a dietary soya lecithin product and corn oil on lipoprotein lipids in normolipidemic and familial hypercholesterolemic subjects. Atherosclerosis 38: 217-222, 1981.
26. Wojcickl J, Pawlik A, Samochawiee L, Katdenska M, Mysliwiec Z: Clinical evaluation of lecithin as a lipid-lowering agent. Short communication. Phytother Res 9: 597-599, 1995.
27. Cobb M, Turkki P, Linscheer W, Raheja K: Lecithin supplementation in healthy volunteers. Nutr Metab 24: 228-237, 1980.
28. Pollak OJ, Kritchevsky D: Sitosterol. In Clarkson TB, Kritchevsky D, Pollak OJ (eds): “Monographs on Atherosclerosis,” vol. 10. Basel (Switzerland): Karger, pp 60-113, 1981.
29. Heinemann T, Kullak-Ublick GA, Pietruck BJ: Mechanisms of action of plant sterols on inhibition of cholesterol absorption. Comparison of sitosterol and sitostanol. Eur J Clin Pharmacol 40(Suppl 1): 59S-63S, 1991.
30. Ikeda I, Sugano M: Inhibition of cholesterol absorption by plant sterols for mass intervention. Curr Opin Lipidol 9: 527-531, 1998.
31. Jenkins DJA, Kendall CWC: Plant sterols, health claims, and strategies to reduce cardiovascular disease risk. J Am Coll Nutr 18: 559-562, 1999.
32. Nguyen TT: The cholesterol-lowering action of plant stanol esters. J Nutr 129: 2109-2112, 1999.
33. Sugano M, Morioka H, Ikeda I: A comparison of hypocholesterolemic activity of -sitosterol and -sitostanol in rats. J Nutr 107: 2011-2019, 1977.
34. Ikeda I, Kawasaki A, Samezima K, Sugano M: Antihypercholesterolemic activity of -sitostanol in rabbits. J Nutr Sci Vitaminol 27: 243-251, 1981.
35. Ikeda I, Sugano M: Comparison of absorption and metabolism of beta-sitosterol and beta-sitostanol in rats. Atherosclerosis 30: 227-237, 1978.
36. Ntanios FY, Jones PJH: Dietary sitostanol reciprocally influences cholesterol absorption and biosynthesis in hamsters and rabbits. Atherosclerosis 143: 341-351, 1999.
37. Becker M, Staab D, von Bergmann K: Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr 122: 292-296, 1993.
38. Heinemann T, Axtmann G, von Bergmann K: Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 23: 827-831, 1993.
39. Westrate JA, Meijer GW: Plant sterol-enriched margarines and reduction of plasma total and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 52: 334-343, 1998.
40. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartainen E: Serum cholesterol lowering by sitostanol ester margarine in a mildly hypercholesterolemic random population. N Engl J Med 333: 1308-1312, 1995.
41. Williams CL, Bollella MC, Strobino BA, Boccia L, Campanaro L: Plant stanol ester and bran fiber in childhood: effects on lipids, stool weight, and stool frequency in preschool children. J Am Coll Nutr 18: 572-581, 1999.
42. Jones PJH, MacDougall DE, Ntanios F, Vanstone CA: Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol 75: 217-227, 1997.
43. Hallikainen MA, Uusitupa MIJ: Effects of 2 low-fat stanol estercontaining margarines as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr 69: 403-410, 1999.
44. Gylling H, Radhakrishnan R, Miettinen TA: Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Circulation 96: 4226-4231, 1997.
45. Gylling H, Miettinen TA: Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37: 773-780, 1994.
46. Gylling H, Miettinen TA: The effects of inhibiting cholesterol synthesis and absorption on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin dependent diabetic men. J Lipid Res 31: 1776-1785, 1996.
47. Mattson FH, Volpenhein RA, Erickson BA: Effect of plant sterolesters on the absorption of dietary cholesterol. J Nutr 107: 1139-1146, 1977.
48. Heinemann T, Pietruck B, Kullak-Ublick G, von Bergmann K: Comparison of sitosterol and sitostanol inhibition of intestinal cholesterol absorption. Agents Actions 26: 117S-122S, 1988.
49. Jones PJ, Sarjaz-Raeini M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE: Modulation of plasma lipid levels and kinetics by phytosterol versus phytostanol esters. J Lipid Res 41: 697-705, 2000.
50. Lichtenstein AH, Ausman LM, Carrasco W, Gualtieri LJ, Jenner JL, Ordovas JM, Nicolosi RJ, Goldin BR, Schaefer EJ: Rice bran oil consumption and plasma lipid levels in moderately hypercholesterolemic humans. Arterioscler Thromb 14: 1549-1556, 1994.
51. Wilson TA, DeSimone AP, Romano CA, Nicolosi RJ: Corn fiber oil lowers plasma cholesterol levels and increases cholesterol excretion greater than corn oil and similar diets containing soy sterols and soy stanols. J Nutr Biochem 11: 443-449, 2000.
52. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study. Lancet 342: 1007-1011, 1993.
53. Lichtenstein AH: Soy protein, isoflavones and cardiovascular disease risk. J Nutr 128: 1589-1592, 1998.
54. Wojcicki J, Rozewicka L, Barcew-Wiszniewska B et al: Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 87: 9-16, 1991.
55. Keaney JF, Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT, Loscalzo J, Vita JA: Low dose -tocopherol improves and high dose -tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 93: 844-851, 1994.
56. Verlangieri AJ, Bush MJ: Effects of -tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 11: 131-138, 1992.
57. Stampfer MJ, Hennekens CH, Manson JE et al: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328: 1444-1449, 1993.
58. Rimm EB, Stampfer J, Ascherio A, et al: Vitamin E consumption and risk of coronary heart disease in men. N Engl J Med 328: 1450-1456, 1993.
59. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781-786, 1996.
60. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-1035, 1994.
61. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455, 1999.
62. The HOPE Study Investigators. The HOPE (Heart Outcomes Prevention Evaluation) Study: Vitamin E supplementation and cardiovascular events in high risk patients. N Engl J Med 342: 154-160, 2000.
63. Stampfer MJ, Malinow R, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH: A prospective study of plasma homocysteine and risk of myocardial infarction in US Physicians. JAMA 268: 877-881, 1992.
64. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155, 1991.
65. Coen DA, Weijenberg MP, van den Berg M, Jakobs C, Feskens JM, Kromhout D: Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men A 10 year follow-up. Arterioscler Thromb Vasc Biol 18: 1895-1901, 1998.
66. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 340: 1449-1454, 1999.
67. Brattstrom LE, Israelsson B, Jeppson JO, Hultberg BL: Folic acid an inocuous means to reduce plasma homocysteine. Scand J Clin Invest 48: 215-221, 1988.
68. Van der Griend R, Haas FJLM, Biesma DH, Duran M, Meuwissen OJATh, Banga JD: Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with pre-mature arterial disease and their relatives. Atherosclerosis 143: 177-183, 1999.
69. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ: Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinaemia. Am J Clin Nutr. 57: 47-53, 1993.
70. Olszewski AJ, Szostak WB, Bialkowska M, Rudnicki S, McCully KS: Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis. Atherosclerosis 75: 1-6, 1989.